Study Links Legal Recreational Cannabis Sales to Increased Heart Hospitalizations

A new study published in the journal BMJ Open examines the potential cardiovascular impacts of recreational cannabis legalization in the United States. Researchers analyzed more than 50 million hospitalizations between 2012 and 2018 using the National Inpatient Sample, covering approximately 97 percent of the U.S. population.

The research team compared 13 states—including California, Colorado, Oregon, Washington, and Alaska—that began permitting recreational cannabis sales in January 2014, against other regions where laws remained unchanged. The findings indicate that each additional year of legal retail sales was associated with a measurable rise in hospital admissions for specific cardiac conditions.

Key Findings on Heart Health

According to the data, every year of legal availability correlated with an increase in hospitalizations for three primary heart issues:

• Heart attacks: a rise of slightly more than 3 percent per year.

• Heart failure: an increase of nearly 4 percent per year.

• Atrial fibrillation, a common heart rhythm disorder: a rise of just over 2 percent per year.

While strokes, blood clots, and other dangerous arrhythmias appeared more frequently in the data, the differences were not deemed statistically significant. The authors noted that observational research cannot definitively prove direct causation, but emphasized that the findings point to potential public health risks associated with legalization.

Study Limitations and Context

Study authors highlighted important methodological caveats. The research did not track individual cannabis consumers, but instead evaluated population-wide trends before and after legislative changes, making it impossible to confirm whether hospitalized patients actually used cannabis. Furthermore, researchers could not distinguish between consumption methods, such as smoking versus edibles or oils, nor could they fully account for shifts in illicit usage.

Despite these limitations, the study aligns with prior scientific literature linking cannabis use—particularly smoking—to cardiovascular complications. Experts suggest that as policymakers worldwide continue debating legalization frameworks, public health systems must closely monitor hospital admission trends following legislative shifts.